Osimertinib dimesylate 0-anthracenedione is orally available cyclin-dependent kinase

is orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway

Hamouda AK

in Male Rats: Effect on Some Physical Attributes and Acetylcholinesterase Activity

In hemophilia A and von Willebrand disease

Osimertinib dimesylate 0-anthracenedione is orally available cyclin-dependent kinaseOsimertinib dimesylate (AZD 9291 dimesylate) is an irreversible and mutant selective EGFR inhibitor with IC50s of 12 and 1 nM against EGFRL858R and EGFRL858R T790M, respectively. Product information CAS Number: 2070014 82 1 Molecular Weight: 691. 82 Formula: C30H41N7O8S2 Chemical Name: N (2 {[2 (dimethylamino)ethyl](methyl)amino} 4 methoxy 5 {[4 (1 methyl 1H indol 3 yl)pyrimidin 2 yl]amino}phenyl)prop 2 enamide; bis(methanesulfonic acid) Smiles: